Suppr超能文献

[中国中药不良反应监测的现状与发展]

[Current status and development of monitoring on adverse reaction of traditional Chinese medicine in China].

作者信息

Zhang Li, Yang Xiao-hui, Cao Li-ya, Ji Shaoliang

机构信息

Food and Drug Administration, Beijing.

出版信息

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2005 Jul;25(7):581-4.

Abstract

With the wide usage of traditional Chinese medicine (TCM) and the diversity of its dosage-forms, the reports about adverse reaction (ADR) caused by TCM were gradually increased. As the cradle of TCM with tremendous manufacturing enterprise engaged for this purpose, to establish and perfect the TCM ADR monitoring is the problem that TCM industry should face to. In this paper, the key point of TCM ADR monitoring was made clear by analysing the current situation and the problems presented in TCM ADR monitoring in China, and indicated that the nowday developing goals of TCM ADR monitoring are to establish and perfect the technologic system for TCM ADR monitoring, strengthen the related basic research and enhance international communication and cooperation in this field.

摘要

随着中药的广泛应用及其剂型的多样化,有关中药引起不良反应(ADR)的报道逐渐增多。作为中药的发源地且有众多企业致力于此,建立和完善中药不良反应监测是中药行业应面对的问题。本文通过分析我国中药不良反应监测的现状及存在的问题,明确了中药不良反应监测的要点,并指出当前中药不良反应监测的发展目标是建立和完善中药不良反应监测技术体系,加强相关基础研究,加强该领域的国际交流与合作。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验